Nature of the Event

Regulatory disclosure of the notice for the 37th Annual General Meeting (AGM) scheduled to be held on September 28, 2026, through video conferencing or other audio-visual means, pursuant to SEBI Listing Regulations.

Key Quantitative Figures and Limits

  • Borrowing Limit: Seeking approval for aggregate borrowing not exceeding ₹500 Crores (Rupees Five Hundred Crores Only) outstanding at any time under Section 180(1)(c).
  • Loans/Guarantees/Investments Limit: Seeking approval for aggregate outstanding loans, guarantees, securities, and investments not exceeding ₹600 Crores (Rupees Six Hundred Crores Only) at any time under Section 186.
  • Loans to Related Entities: Seeking approval for loans/guarantees/security to subsidiaries, associates, joint ventures, or group entities not exceeding ₹200 Crores (Rupees Two Hundred Crores Only) under Section 185.
  • Sitting Fees: Mrs. Anjana Dikshit received sitting fees of ₹3.47 Lacs during the financial year 2025-26.
  • Shareholding: Mrs. Abha Mittal holds 15,700 equity shares (0.05% of paid-up capital).

Parties Involved

  • Company Secretary & Compliance Officer: Pratap Singh (M. No.: A24081)
  • Scrutinizer: Mr. Raj Kumar Banthia, Company Secretary in Practice (Membership No. 17190 & CP No. 18428), Partner of M/s. MKB & Associates
  • RTA: MUFG Intime India Private Limited (formerly Link Intime India Private Limited)
  • Director Seeking Re-appointment: Mrs. Abha Mittal (DIN: 00519777) retires by rotation.
  • Independent Director Seeking Re-appointment: Mrs. Anjana Dikshit (DIN: 10377490) for a second term from November 10, 2026, to November 9, 2031.

Purpose/Rationale

  • To conduct ordinary business including adoption of audited financial statements and director appointments.
  • To seek approvals for enhanced borrowing limits, creation of security on assets, and making loans/investments in other entities to support long-term strategic and business objectives.
  • To comply with statutory requirements under the Companies Act, 2013, and SEBI Listing Regulations.

Financial/Operational Impact

  • Approval of resolutions will enable the company to raise funds up to ₹500 Crores for business needs.
  • Authorization to provide loans/guarantees/investments up to ₹600 Crores to other entities.
  • Ability to create mortgages/charges on company assets to secure borrowings.
  • Re-appointment of directors ensures continuity in governance.

Capital Structure Impact

No direct impact on share capital disclosed. Resolutions relate to borrowing, lending, and investments, not equity issuance.

Cash Flow Implications

Potential future cash outflows from loans given or investments made, and inflows from borrowings raised, subject to approvals and business needs.

Forward-Looking Guidance

No explicit forward-looking guidance or management commentary provided in the notice.

Material Changes

  • The company changed its name from Sastasundar Ventures Limited to Health X Platform Limited.
  • Revenue bifurcation provided for the period from January 1, 2025, to December 31, 2025: Healthcare Activity ₹1,20,971.84 lakhs, Financial Services activity ₹2,160.79 lakhs, Total ₹1,23,132.63 lakhs.